Broadcom
AVGO
Taiwan Semiconductor
TSM
Tesla
TSLA
ASML Holding
ASML
Qualcomm
QCOM
US Stock MarketDetailed Quotes
MNMD Mind Medicine
- 7.1600
- +0.1400+1.99%
Close Dec 13 16:00 ET
- 7.1500
- -0.0100-0.14%
Post 20:01 ET
525.05MMarket Cap-4.19P/E (TTM)
7.2900High6.9000Low1.19MVolume7.0200Open7.0200Pre Close8.38MTurnover2.22%Turnover RatioLossP/E (Static)73.33MShares12.220052wk High2.00P/B382.59MFloat Cap3.270052wk Low--Dividend TTM53.43MShs Float86.5500Historical High--Div YieldTTM5.56%Amplitude2.1200Historical Low7.0620Avg Price1Lot Size
Mind Medicine News
MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
Mind Medicine Gets UK's Innovation Passport Designation for Investigational Anxiety Disorder Treatment
Express News | Mind Medicine: Awarded Innovation Passport Designation by UK Ilap Steering Group for Mm120 Odt for Generalized Anxiety Disorder
Express News | MindMed Appoints Javier Muniz, M.d., as Vice President of Research and Development Strategy
MindMed Announces New Employee Inducement Grants
RBC Capital Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $21
RBC Capital Remains a Buy on Mind Medicine (MNMD)
Mind Medicine Appoints Gregg Pratt Chief Regulatory, Quality Assurance Officer
Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading Into 2025?
RFK and the 'MAHA Trade': Vaccine Makers Down, Psychedelic Shares up
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) Market Cap Touched US$601m Last Week, Benefiting Both Retail Investors Who Own 41% as Well as Institutions
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
MindMed to Participate in Upcoming Investor Conferences
Express News | Mind Medicine Shares Are Trading Higher. HC Wainwright & Co. Reiterated a Buy Rating on the Stock
Mind Medicine Analyst Ratings
Optimistic Outlook for Mind Medicine Amidst Promising Phase 3 Developments and Robust Financial Health
Maxim Group Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $18
Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20
H.C. Wainwright Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $55
Express News | Mind Medicine Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.